Literature DB >> 24835768

Cancer cells with irons in the fire.

Laura M Bystrom1, Stefano Rivella2.   

Abstract

Iron is essential for the growth and proliferation of cells, as well as for many biological processes that are important for the maintenance and survival of the human body. However, excess iron is associated with the development of cancer and other pathological conditions, due in part to the pro-oxidative nature of iron and its damaging effects on DNA. Current studies suggest that iron depletion may be beneficial for patients that have diseases associated with iron overload or other iron metabolism disorders that may increase the risk for cancer. On the other hand, studies suggest that cancer cells are more vulnerable to the effects of iron depletion and oxidative stress in comparison to normal cells. Therefore, cancer patients might benefit from treatments that alter both iron metabolism and oxidative stress. This review highlights the pro-oxidant effects of iron, the relationship between iron and cancer development, the vulnerabilities of the iron-dependent cancer phenotype, and how these characteristics may be exploited to prevent or treat cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Free radicals; Iron; Iron chelators; Iron overload; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 24835768      PMCID: PMC4232494          DOI: 10.1016/j.freeradbiomed.2014.04.035

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  71 in total

1.  Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.

Authors:  Sara Gardenghi; Pedro Ramos; Maria Franca Marongiu; Luca Melchiori; Laura Breda; Ella Guy; Kristen Muirhead; Niva Rao; Cindy N Roy; Nancy C Andrews; Elizabeta Nemeth; Antonia Follenzi; Xiuli An; Narla Mohandas; Yelena Ginzburg; Eliezer A Rachmilewitz; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal.

Authors:  Yang-Sung Sohn; Anna-Maria Mitterstiller; William Breuer; Guenter Weiss; Z Ioav Cabantchik
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer.

Authors:  Chi-Chen Hong; Christine B Ambrosone; Jiyoung Ahn; Ji-Yeob Choi; Marjorie L McCullough; Victoria L Stevens; Carmen Rodriguez; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08-28       Impact factor: 4.254

Review 4.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

5.  Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia.

Authors:  Toshihiro Fukushima; Hiroshi Kawabata; Takuji Nakamura; Haruka Iwao; Akio Nakajima; Miyuki Miki; Tomoyuki Sakai; Toshioki Sawaki; Yoshimasa Fujita; Masao Tanaka; Yasufumi Masaki; Yuko Hirose; Hisanori Umehara
Journal:  Anticancer Res       Date:  2011-05       Impact factor: 2.480

6.  Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.

Authors:  H L Elford; M Freese; E Passamani; H P Morris
Journal:  J Biol Chem       Date:  1970-10-25       Impact factor: 5.157

Review 7.  Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis.

Authors:  Joseph E Maakaron; Maria Domenica Cappellini; Giovanna Graziadei; Jad Bou Ayache; Ali T Taher
Journal:  Ann Hepatol       Date:  2013 Jan-Feb       Impact factor: 2.400

8.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

Review 9.  Oxidative stress in the regulation of normal and neoplastic hematopoiesis.

Authors:  Saghi Ghaffari
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

Review 10.  Iron deprivation in cancer--potential therapeutic implications.

Authors:  Jessica L Heath; Joshua M Weiss; Catherine P Lavau; Daniel S Wechsler
Journal:  Nutrients       Date:  2013-07-24       Impact factor: 5.717

View more
  26 in total

1.  Prooxidant and antioxidant properties of salicylaldehyde isonicotinoyl hydrazone iron chelators in HepG2 cells.

Authors:  Andres A Caro; Ava Commissariat; Caroline Dunn; Hyunjoo Kim; Salvador Lorente García; Allen Smith; Harrison Strang; Jake Stuppy; Linda P Desrochers; Thomas E Goodwin
Journal:  Biochim Biophys Acta       Date:  2015-08-11

Review 2.  Overview of iron metabolism in health and disease.

Authors:  Som Dev; Jodie L Babitt
Journal:  Hemodial Int       Date:  2017-03-15       Impact factor: 1.812

Review 3.  Iron and cancer: recent insights.

Authors:  David H Manz; Nicole L Blanchette; Bibbin T Paul; Frank M Torti; Suzy V Torti
Journal:  Ann N Y Acad Sci       Date:  2016-02-18       Impact factor: 5.691

4.  Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients.

Authors:  Ana Cristina Gonçalves; Emília Cortesão; Barbara Oliveiros; Vera Alves; Ana Isabel Espadana; Luís Rito; Emília Magalhães; Sónia Pereira; Amélia Pereira; José Manuel Nascimento Costa; Luisa Mota-Vieira; Ana Bela Sarmento-Ribeiro
Journal:  Clin Exp Med       Date:  2015-05-17       Impact factor: 3.984

Review 5.  Mitochondria and Iron: current questions.

Authors:  Bibbin T Paul; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2016-12-12       Impact factor: 2.929

6.  Bioinformatics analysis of downstream circRNAs and miRNAs regulated by Runt-related transcription factor 1 in papillary thyroid carcinoma.

Authors:  Jiajie Xu; Guowan Zheng; Haiwei Guo; Kexin Meng; Wanchen Zhang; Ru He; Chuanming Zheng; Minghua Ge
Journal:  Gland Surg       Date:  2022-05

Review 7.  Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.

Authors:  Bojana Ristic; Yangzom D Bhutia; Vadivel Ganapathy
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-05-13       Impact factor: 10.680

8.  Hemochromatosis: a model of metal-related human toxicosis.

Authors:  Pierre Brissot; Thibault Cavey; Martine Ropert; François Gaboriau; Olivier Loréal
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-15       Impact factor: 4.223

9.  Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.

Authors:  Yanru Xue; Gejing Zhang; Shoujie Zhou; Shenghang Wang; Huanhuan Lv; Liangfu Zhou; Peng Shang
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

Review 10.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.